Craig-Hallum initiated coverage of Cerus with a Buy rating and $5 price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CERS:
- FDA approves Cerus’ 12-month shelf life for INTERCEPT platelet processing sets
- Biotech Alert: Searches spiking for these stocks today
- Cathie Wood’s ARK Investment bought 193K shares of Cerus today
- Cerus announces ReCePI trial met primary efficacy endpoint
- Cathie Wood’s ARK Investment bought 278K shares of Cerus today